Circulating Epithelial Tumor Cell (CETC) Monitoring during SERM and Aromatase Inhibitor Treatment for Early Detection of Patients Resistant to Tamoxifen.

被引：0
作者：
Pachmann, K.
Camara, O.
Rabenstein, C.
Winzer, H.
Runnebaum, I. B.
机构：
[1] Univ Jena, Univ Hosp, Jena, Germany
[2] Transfus Ctr, Bayreuth, Germany
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：808S / 809S
页数：2
相关论文
共 50 条
  • [21] Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant breast cancer treatment including bevacizumab
    Mathiesen, R. R.
    Borgen, E.
    Saetersdal, A. B.
    Fangberget, A.
    Schirmer, C.
    Stav, I.
    Fagerland, M. W.
    Wist, E.
    Engebraten, O.
    Naume, B.
    CANCER RESEARCH, 2013, 73
  • [22] Circulating tumor DNA for early relapse detection and monitoring disease status in patients with early-stage pancreatic adenocarcinoma
    Abdelrahim, M.
    Esmail, A.
    Katz, T.
    Sharma, S.
    Kalashnikova, E.
    Malhotra, M.
    Olshan, P.
    Billings, P.
    Aleshin, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S135 - S135
  • [23] Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy
    Mikulova, Veronika
    Cabinakova, Michaela
    Janatkova, Ivana
    Mestek, Otto
    Zima, Tomas
    Tesarova, Petra
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (02) : 132 - 142
  • [24] Circulating Tumor DNA for Early Relapse Detection and Monitoring Disease Status in Patients With Early-Stage Pancreatic Adenocarcinoma
    Abdelrahim, M.
    Chandana, S.
    Esmail, A.
    Katz, T. A.
    Drummond, B.
    Sharma, S.
    Kalashnikova, E.
    Olshan, P.
    Billings, P. R.
    Aleshin, A.
    PANCREAS, 2021, 50 (07) : 1044 - 1045
  • [25] Arthralgia During Aromatase Inhibitor Treatment in Early Breast Cancer Patients Prevalence, Impact, and Recognition by Healthcare Providers
    Boonstra, Amilie
    van Zadelhoff, Joost
    Timmer-Bonte, Anja
    Ottevanger, Petronella B.
    Beurskens, Carien H. G.
    van Laarhoven, Hanneke W. M.
    CANCER NURSING, 2013, 36 (01) : 52 - 59
  • [26] Switching to aromatase inhibitor (AI) after tamoxifen in premenopausal patients with chemotherapy-induced amenorrhea (CIA) after early breast cancer treatment
    Perez-Fidalgo, J. A.
    Miranda, M. J.
    Bermejo, B.
    Pons, V.
    Rosello, S.
    Garcia-Garre, E.
    Guzman, C.
    Lluch, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Supervising circulating tumor cells during and beyond maintenance therapy with SERM or aromatase inhibitors. A way to better support our patients to make decisions in long-term survivorship
    Pachmann, K.
    Rabenstein, C.
    Camara, O.
    Ingo, R. B.
    Ulrich, P.
    CANCER RESEARCH, 2013, 73
  • [28] Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
    Hofman, Veronique
    Bonnetaud, Christelle
    Ilie, Marius I.
    Vielh, Philippe
    Vignaud, Jean Michel
    Flejou, Jean Francois
    Lantuejoul, Sylvie
    Piaton, Eric
    Mourad, Nadine
    Butori, Catherine
    Selva, Eric
    Poudenx, Michel
    Sibon, Stephanie
    Kelhef, Sabrina
    Venissac, Nicolas
    Jais, Jean-Philippe
    Mouroux, Jerome
    Molina, Thierry Jo
    Hofman, Paul
    CLINICAL CANCER RESEARCH, 2011, 17 (04) : 827 - 835
  • [29] Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients
    Hekimian, Katya
    Stein, Ernst-Ludwig
    Pachmann, Ulrich
    Pachmann, Katharina
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (04) : 701 - 708
  • [30] Circulating tumor cell detection predicts early recurrence in patients with non-metastatic breast cancer
    Hall, C.
    Meas, S.
    Bauldry, J. Bowman
    Kuerer, H.
    Lucci, A.
    CANCER RESEARCH, 2019, 79 (04)
12345